CRISPR Therapeutics AG (CRSP) Asset Utilization Ratio (2016 - 2026)

CRISPR Therapeutics AG (CRSP) has 11 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 90.38% year-over-year to 0.0; the trailing twelve-month figure through Mar 2026 stood at 0.0 (down 90.38% YoY), and the FY2025 full-year result was 0.0, down 90.67% from the prior year.
• Asset Utilization Ratio rose to 0.0 in Q1 2026, from 0.0 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.34 in Q1 2022 to a low of 0.0 in Q4 2022.
• A 5-year average of 0.06 and a median of 0.02 in 2025 frame the typical range for Asset Utilization Ratio.
• Peak annual rise in Asset Utilization Ratio reached 58644.33% in 2022, while the deepest fall reached 99.84% in 2022.
• Tracing CRSP's Asset Utilization Ratio over 5 years: stood at 0.0 in 2022, then soared by 32895.55% to 0.17 in 2023, then slumped by 90.35% to 0.02 in 2024, then tumbled by 90.62% to 0.0 in 2025, then gained by 5.64% to 0.0 in 2026.
• Business Quant data shows CRSP's Asset Utilization Ratio at 0.0 in Q1 2026, 0.0 in Q4 2025, and 0.02 in Q3 2025.